MetLife Investment Management, LLC
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,698,496
+$498,850 QoQ
Shares Held
41,804
+9.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#98
of 225 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. EWTX ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in EWTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,698,496 | 41,804 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,199,646 | 38,084 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $950,191 | 38,291 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $711,782 | 43,883 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $575,306 | 43,883 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $965,426 | 43,883 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,191,140 | 44,612 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,128,212 | 42,271 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $761,300 | 42,271 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $546,014 | 29,935 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $255,503 | 23,355 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $133,824 | 23,355 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $181,001 | 23,355 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $155,777 | 23,355 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $208,793 | 23,355 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $229,813 | 23,355 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $185,905 | 23,355 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $226,543 | 23,355 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $229,612 | 15,027 | Shares | Defined | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||